NEOK Bio vs 100ms
Side-by-side comparison of AI visibility scores, market position, and capabilities
NEOK Bio emerged from stealth in 2025 with $80M in funding targeting neuroinflammation pathways in Alzheimer's disease and ALS using a novel class of innate immune modulators.
About
NEOK Bio is targeting neuroinflammation — the chronic activation of brain immune cells (microglia and astrocytes) — as a primary driver of neurodegeneration in Alzheimer's disease, ALS, and Parkinson's disease. The company's small molecule drug candidates modulate the NLRP3 inflammasome and related innate immune pathways in the brain, aiming to reduce the toxic inflammatory environment that kills neurons over time.
100ms is a live audio/video infrastructure platform with SDKs for React, iOS, Android, and Flutter, providing programmable rooms, recording, and live streaming for web and mobile apps.
About
100ms is a live audio and video infrastructure platform that provides developers with SDKs and APIs for embedding real-time communication features — video rooms, audio spaces, live streams, and recording — into web and mobile applications. The platform is designed around a room-based model where developers programmatically create, configure, and manage video rooms through a REST API, with client SDKs for React, iOS, Android, Flutter, and React Native handling the media layer. This abstraction allows teams to build fully custom video experiences with their own UI without dealing with WebRTC internals, TURN server management, or media server infrastructure.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.